Latest Breaking News On - Gd2 cart01 - Page 1 : comparemela.com

The investigational CAR T-cell therapy GD2-CART01 showed preliminary antitumor activity and safety in pediatric patients with relapsed or refractory high-risk neuroblastoma, according to data from a phase 1/2 trial.

Ospedale pediatrico bambinoOladapoo yekuDanl longoPrecision medicine teamNew england journalPediatrico bambino gesGd2 cart01Disialoganglioside gd2Cart cell therapyRelapsed or refractory high risk neuroblastomaPhase 1 2 trial nct03373097